Browse By Cell Line Result Page of OvirusTdb
The total number of records retrieved from this search are 16. Click on ID to see further detail.
IDOV_1214 | Virus nameAdenovirus | Virus strainZD55-smac | Virus genome typeDNA | Virus familyAdenoviridae | Virus genome modificationDeletion of E1B-55K gene and addition of smac gene | Virus aloneYes | Virus in combination with drug/radiationNo | Immune gene insertion in viral genomeVirus expressing smac gene | Source of cell lineShanghai cell collection | Origin of cell lineLiver cancer cell line | Cell lineBEL-7407 | Concentration of cell lineNA | In-vitro toxicityNA | AssayMTT assay | In-vitro virus concentration1 MOI | In-vitro result10% cancer cell killing after day 1 | Model organismNo | In-vivo virus concentrationNo | In-vivo toxicityNA | In-vivo resultNo response | Mode of deliveryNA | Pathway inducedNA | Immunogenic effectNA | Clinical trialNA | PMID18031615 |
IDOV_1215 | Virus nameAdenovirus | Virus strainZD55-smac | Virus genome typeDNA | Virus familyAdenoviridae | Virus genome modificationDeletion of E1B-55K gene and addition of smac gene | Virus aloneYes | Virus in combination with drug/radiationNo | Immune gene insertion in viral genomeVirus expressing smac gene | Source of cell lineShanghai cell collection | Origin of cell lineLiver cancer cell line | Cell lineBEL-7407 | Concentration of cell lineNA | In-vitro toxicityNA | AssayMTT assay | In-vitro virus concentration1 MOI | In-vitro result20% cancer cell killing after day 2 | Model organismNo | In-vivo virus concentrationNo | In-vivo toxicityNA | In-vivo resultNo response | Mode of deliveryNA | Pathway inducedNA | Immunogenic effectNA | Clinical trialNA | PMID18031615 |
IDOV_1216 | Virus nameAdenovirus | Virus strainZD55-smac | Virus genome typeDNA | Virus familyAdenoviridae | Virus genome modificationDeletion of E1B-55K gene and addition of smac gene | Virus aloneYes | Virus in combination with drug/radiationNo | Immune gene insertion in viral genomeVirus expressing smac gene | Source of cell lineShanghai cell collection | Origin of cell lineLiver cancer cell line | Cell lineBEL-7407 | Concentration of cell lineNA | In-vitro toxicityNA | AssayMTT assay | In-vitro virus concentration1 MOI | In-vitro result30% cancer cell killing after day 3 | Model organismNo | In-vivo virus concentrationNo | In-vivo toxicityNA | In-vivo resultNo response | Mode of deliveryNA | Pathway inducedNA | Immunogenic effectNA | Clinical trialNA | PMID18031615 |
IDOV_1217 | Virus nameAdenovirus | Virus strainZD55-smac | Virus genome typeDNA | Virus familyAdenoviridae | Virus genome modificationDeletion of E1B-55K gene and addition of smac gene | Virus aloneYes | Virus in combination with drug/radiationNo | Immune gene insertion in viral genomeVirus expressing smac gene | Source of cell lineShanghai cell collection | Origin of cell lineLiver cancer cell line | Cell lineBEL-7407 | Concentration of cell lineNA | In-vitro toxicityNA | AssayMTT assay | In-vitro virus concentration1 MOI | In-vitro result30% cancer cell killing after day 4 | Model organismNo | In-vivo virus concentrationNo | In-vivo toxicityNA | In-vivo resultNo response | Mode of deliveryNA | Pathway inducedNA | Immunogenic effectNA | Clinical trialNA | PMID18031615 |
IDOV_1218 | Virus nameAdenovirus | Virus strainZD55-smac | Virus genome typeDNA | Virus familyAdenoviridae | Virus genome modificationDeletion of E1B-55K gene and addition of smac gene | Virus aloneNo | Virus in combination with drug/radiationZD55-smac in combination with cisplatin (1microgram/ml) | Immune gene insertion in viral genomeVirus expressing smac gene | Source of cell lineShanghai cell collection | Origin of cell lineLiver cancer cell line | Cell lineBEL-7407 | Concentration of cell lineNA | In-vitro toxicityNA | AssayMTT assay | In-vitro virus concentration1 MOI | In-vitro result10% cancer cell killing after day 1 | Model organismNo | In-vivo virus concentrationNo | In-vivo toxicityNA | In-vivo resultNo response | Mode of deliveryNA | Pathway inducedNA | Immunogenic effectNA | Clinical trialNA | PMID18031615 |
IDOV_1219 | Virus nameAdenovirus | Virus strainZD55-smac | Virus genome typeDNA | Virus familyAdenoviridae | Virus genome modificationDeletion of E1B-55K gene and addition of smac gene | Virus aloneNo | Virus in combination with drug/radiationZD55-smac in combination with cisplatin (1microgram/ml) | Immune gene insertion in viral genomeVirus expressing smac gene | Source of cell lineShanghai cell collection | Origin of cell lineLiver cancer cell line | Cell lineBEL-7407 | Concentration of cell lineNA | In-vitro toxicityNA | AssayMTT assay | In-vitro virus concentration1 MOI | In-vitro result30% cancer cell killing after day 2 | Model organismNo | In-vivo virus concentrationNo | In-vivo toxicityNA | In-vivo resultNo response | Mode of deliveryNA | Pathway inducedNA | Immunogenic effectNA | Clinical trialNA | PMID18031615 |
IDOV_1220 | Virus nameAdenovirus | Virus strainZD55-smac | Virus genome typeDNA | Virus familyAdenoviridae | Virus genome modificationDeletion of E1B-55K gene and addition of smac gene | Virus aloneNo | Virus in combination with drug/radiationZD55-smac in combination with cisplatin (1microgram/ml) | Immune gene insertion in viral genomeVirus expressing smac gene | Source of cell lineShanghai cell collection | Origin of cell lineLiver cancer cell line | Cell lineBEL-7407 | Concentration of cell lineNA | In-vitro toxicityNA | AssayMTT assay | In-vitro virus concentration1 MOI | In-vitro result50% cancer cell killing after day 3 | Model organismNo | In-vivo virus concentrationNo | In-vivo toxicityNA | In-vivo resultNo response | Mode of deliveryNA | Pathway inducedNA | Immunogenic effectNA | Clinical trialNA | PMID18031615 |
IDOV_1221 | Virus nameAdenovirus | Virus strainZD55-smac | Virus genome typeDNA | Virus familyAdenoviridae | Virus genome modificationDeletion of E1B-55K gene and addition of smac gene | Virus aloneNo | Virus in combination with drug/radiationZD55-smac in combination with cisplatin (1microgram/ml) | Immune gene insertion in viral genomeVirus expressing smac gene | Source of cell lineShanghai cell collection | Origin of cell lineLiver cancer cell line | Cell lineBEL-7407 | Concentration of cell lineNA | In-vitro toxicityNA | AssayMTT assay | In-vitro virus concentration1 MOI | In-vitro result50% cancer cell killing after day 4 | Model organismNo | In-vivo virus concentrationNo | In-vivo toxicityNA | In-vivo resultNo response | Mode of deliveryNA | Pathway inducedNA | Immunogenic effectNA | Clinical trialNA | PMID18031615 |
IDOV_1222 | Virus nameAdenovirus | Virus strainZD55-smac | Virus genome typeDNA | Virus familyAdenoviridae | Virus genome modificationDeletion of E1B-55K gene and addition of smac gene | Virus aloneYes | Virus in combination with drug/radiationNo | Immune gene insertion in viral genomeVirus expressing smac gene | Source of cell lineShanghai cell collection | Origin of cell lineLiver cancer cell line | Cell lineBEL-7407 | Concentration of cell lineNA | In-vitro toxicityNA | AssayMTT assay | In-vitro virus concentration1 MOI | In-vitro result7% cancer cell killing after day 1 | Model organismNo | In-vivo virus concentrationNo | In-vivo toxicityNA | In-vivo resultNo response | Mode of deliveryNA | Pathway inducedNA | Immunogenic effectNA | Clinical trialNA | PMID18031615 |
IDOV_1223 | Virus nameAdenovirus | Virus strainZD55-smac | Virus genome typeDNA | Virus familyAdenoviridae | Virus genome modificationDeletion of E1B-55K gene and addition of smac gene | Virus aloneYes | Virus in combination with drug/radiationNo | Immune gene insertion in viral genomeVirus expressing smac gene | Source of cell lineShanghai cell collection | Origin of cell lineLiver cancer cell line | Cell lineBEL-7407 | Concentration of cell lineNA | In-vitro toxicityNA | AssayMTT assay | In-vitro virus concentration1 MOI | In-vitro result17% cancer cell killing after day 2 | Model organismNo | In-vivo virus concentrationNo | In-vivo toxicityNA | In-vivo resultNo response | Mode of deliveryNA | Pathway inducedNA | Immunogenic effectNA | Clinical trialNA | PMID18031615 |
IDOV_1224 | Virus nameAdenovirus | Virus strainZD55-smac | Virus genome typeDNA | Virus familyAdenoviridae | Virus genome modificationDeletion of E1B-55K gene and addition of smac gene | Virus aloneYes | Virus in combination with drug/radiationNo | Immune gene insertion in viral genomeVirus expressing smac gene | Source of cell lineShanghai cell collection | Origin of cell lineLiver cancer cell line | Cell lineBEL-7407 | Concentration of cell lineNA | In-vitro toxicityNA | AssayMTT assay | In-vitro virus concentration1 MOI | In-vitro result50% cancer cell killing after day 3 | Model organismNo | In-vivo virus concentrationNo | In-vivo toxicityNA | In-vivo resultNo response | Mode of deliveryNA | Pathway inducedNA | Immunogenic effectNA | Clinical trialNA | PMID18031615 |
IDOV_1225 | Virus nameAdenovirus | Virus strainZD55-smac | Virus genome typeDNA | Virus familyAdenoviridae | Virus genome modificationDeletion of E1B-55K gene and addition of smac gene | Virus aloneYes | Virus in combination with drug/radiationNo | Immune gene insertion in viral genomeVirus expressing smac gene | Source of cell lineShanghai cell collection | Origin of cell lineLiver cancer cell line | Cell lineBEL-7407 | Concentration of cell lineNA | In-vitro toxicityNA | AssayMTT assay | In-vitro virus concentration1 MOI | In-vitro result50% cancer cell killing after day 4 | Model organismNo | In-vivo virus concentrationNo | In-vivo toxicityNA | In-vivo resultNo response | Mode of deliveryNA | Pathway inducedNA | Immunogenic effectNA | Clinical trialNA | PMID18031615 |
IDOV_1226 | Virus nameAdenovirus | Virus strainZD55-smac | Virus genome typeDNA | Virus familyAdenoviridae | Virus genome modificationDeletion of E1B-55K gene and addition of smac gene | Virus aloneNo | Virus in combination with drug/radiationZD55-smac in combination with 5 FU (5 microgram/ml) | Immune gene insertion in viral genomeVirus expressing smac gene | Source of cell lineShanghai cell collection | Origin of cell lineLiver cancer cell line | Cell lineBEL-7407 | Concentration of cell lineNA | In-vitro toxicityNA | AssayMTT assay | In-vitro virus concentration1 MOI | In-vitro result7% cancer cell killing after day 1 | Model organismNo | In-vivo virus concentrationNo | In-vivo toxicityNA | In-vivo resultNo response | Mode of deliveryNA | Pathway inducedNA | Immunogenic effectNA | Clinical trialNA | PMID18031615 |
IDOV_1227 | Virus nameAdenovirus | Virus strainZD55-smac | Virus genome typeDNA | Virus familyAdenoviridae | Virus genome modificationDeletion of E1B-55K gene and addition of smac gene | Virus aloneNo | Virus in combination with drug/radiationZD55-smac in combination with 5 FU (5 microgram/ml) | Immune gene insertion in viral genomeVirus expressing smac gene | Source of cell lineShanghai cell collection | Origin of cell lineLiver cancer cell line | Cell lineBEL-7407 | Concentration of cell lineNA | In-vitro toxicityNA | AssayMTT assay | In-vitro virus concentration1 MOI | In-vitro result30% cancer cell killing after day 2 | Model organismNo | In-vivo virus concentrationNo | In-vivo toxicityNA | In-vivo resultNo response | Mode of deliveryNA | Pathway inducedNA | Immunogenic effectNA | Clinical trialNA | PMID18031615 |
IDOV_1228 | Virus nameAdenovirus | Virus strainZD55-smac | Virus genome typeDNA | Virus familyAdenoviridae | Virus genome modificationDeletion of E1B-55K gene and addition of smac gene | Virus aloneNo | Virus in combination with drug/radiationZD55-smac in combination with 5 FU (5 microgram/ml) | Immune gene insertion in viral genomeVirus expressing smac gene | Source of cell lineShanghai cell collection | Origin of cell lineLiver cancer cell line | Cell lineBEL-7407 | Concentration of cell lineNA | In-vitro toxicityNA | AssayMTT assay | In-vitro virus concentration1 MOI | In-vitro result50% cancer cell killing after day 3 | Model organismNo | In-vivo virus concentrationNo | In-vivo toxicityNA | In-vivo resultNo response | Mode of deliveryNA | Pathway inducedNA | Immunogenic effectNA | Clinical trialNA | PMID18031615 |
IDOV_1229 | Virus nameAdenovirus | Virus strainZD55-smac | Virus genome typeDNA | Virus familyAdenoviridae | Virus genome modificationDeletion of E1B-55K gene and addition of smac gene | Virus aloneNo | Virus in combination with drug/radiationZD55-smac in combination with 5 FU (5 microgram/ml) | Immune gene insertion in viral genomeVirus expressing smac gene | Source of cell lineShanghai cell collection | Origin of cell lineLiver cancer cell line | Cell lineBEL-7407 | Concentration of cell lineNA | In-vitro toxicityNA | AssayMTT assay | In-vitro virus concentration1 MOI | In-vitro result50% cancer cell killing after day 4 | Model organismNo | In-vivo virus concentrationNo | In-vivo toxicityNA | In-vivo resultNo response | Mode of deliveryNA | Pathway inducedNA | Immunogenic effectNA | Clinical trialNA | PMID18031615 |